The NPM1 mutation type has no impact on survival in cytogenetically normal AML.

PLoS One · 2014 · PMC4192029 · PMID 25299584

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In contrast, another study recently presented at the ASH meeting involving 603 NPM1 -mutated patients with intermediate risk karyotype showed a trend towards a longer OS in rare type versus type A NPM1 mutations [5] .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.